Amidst the backdrop of evolving privacy regulations and the phasing out of traditional digital identifiers, the video explores the essential strategies pharmaceutical advertisers must adopt to navigate these industry challenges and accurately assess the real-world outcomes they are achieving from their advertising. This is a video recording of a speaking session produced in partnership with…

Pharma brand managers have a data problem: namely, they have access to so much of it that it can inundate their decision-making processes. We outline the best ways of streamlining the volume of information and separating the proverbial wheat from the chaff. This is a video recording of a speaking session produced in partnership with…

The use of insights derived from real-world data (RWD) for advertising planning and business development is table stakes, but getting access to that data and compiling insights can be an arduous and resource-intensive process. How does PurpleLab help healthcare advertisers utilize RWD insights? Watch this webinar with Hannah Lucas, Director of Product Management, Advertising, at…

While there has always been a significant focus on how to effectively educate and market products to patients and healthcare providers (HCPs) there is another group that pharmaceutical manufacturers, specifically– Medical Affairs and Marketing teams need to reach, educate, and influence: . KOLs, often the most experienced in a therapy area, who also may be…

Commercial launch strategies require research, insight gathering and decision-making for years in advance of FDA submission. These processes involve complex requirements and often involve timelines and project plans that are mapped out across functional teams and their agency partners. As teams move quickly into “launch mode”, there are many potential shifting priorities requiring contingency plans…

Compared to those in other fields, in many ways, life sciences marketers need much more precision when it comes to audience segmentation and targeting. The pharmaceutical brands that they are advertising often have very precise indications, which means the drug’s value and benefits are only relevant to a niche audience. For example, imagine that your…

Today’s Life Science organizations expend significant resources to capture and hold the attention of patients and healthcare providers (HCPs) in the digital ecosystem. In 2022, the average U.S. consumer spent more than eight hours a day consuming digital content. Physicians are among the busiest employees in the US, as well as consumers— some survey findings…

As organizations in life sciences continue to grow and evolve, the strategies they use to reach healthcare providers (HCPs) and patients are following suit. Doctors and patients are inundated with more and more information across digital and traditional channels about relevant diseases, gold-standard treatments, and their various benefits.